Progyny Q4 revenue up 6.7% to $318.4M; guides FY2026 revenue $1.355B-$1.405B

Progyny, Inc.

2025-FY EPS reported $0.65 revenue$1,288,661,000

Q4 revenue $318.4M (+6.7% YoY); FY2025 revenue $1.2887B (+10% YoY); gross margin expanded to 24.1%.
Q4 net income $12.5M ($0.14 diluted EPS); adj. EPS $0.48; adj. EBITDA $51.4M (16.1% margin).
Full year operating cash flow record $210.2M; repurchased 3.3M shares in Q4, 6.5M total under $200M authorization.
FY2026 revenue guidance $1.355B-$1.405B; adj. EBITDA $224M-$239M; adj. EPS $1.83-$1.95.
Client count 555 as of Dec 2025 (up from 473); expects ~600 clients representing ~7.2M covered lives in 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.